Versor Investments LP lifted its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 60.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,500 shares of the company's stock after acquiring an additional 9,198 shares during the quarter. Versor Investments LP's holdings in DocuSign were worth $2,204,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also modified their holdings of the company. Toronto Dominion Bank lifted its stake in DocuSign by 30.3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company's stock valued at $1,624,000 after acquiring an additional 6,081 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of DocuSign by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company's stock valued at $82,478,000 after purchasing an additional 16,014 shares during the last quarter. Quantinno Capital Management LP boosted its holdings in DocuSign by 39.5% in the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company's stock worth $12,514,000 after purchasing an additional 57,104 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its position in DocuSign by 7.1% during the third quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company's stock worth $80,501,000 after buying an additional 85,987 shares during the last quarter. Finally, Rhumbline Advisers raised its holdings in DocuSign by 118.8% during the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company's stock valued at $54,695,000 after buying an additional 330,136 shares in the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at DocuSign
In other DocuSign news, insider James P. Shaughnessy sold 7,500 shares of the firm's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $90.17, for a total transaction of $676,275.00. Following the completion of the transaction, the insider now owns 43,781 shares in the company, valued at $3,947,732.77. This trade represents a 14.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the sale, the director now directly owns 7,736 shares in the company, valued at $731,825.60. The trade was a 6.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 686,010 shares of company stock valued at $66,102,694. 1.66% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on DOCU shares. Piper Sandler increased their price objective on DocuSign from $60.00 to $90.00 and gave the company a "neutral" rating in a report on Friday, December 6th. Hsbc Global Res raised DocuSign to a "moderate sell" rating in a research report on Friday, December 6th. Royal Bank of Canada reissued a "sector perform" rating and issued a $90.00 price target (up previously from $57.00) on shares of DocuSign in a research report on Friday, December 6th. HSBC reiterated a "reduce" rating on shares of DocuSign in a research note on Friday, December 6th. Finally, Wells Fargo & Company boosted their target price on shares of DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $92.45.
Check Out Our Latest Report on DocuSign
DocuSign Trading Down 1.8 %
DOCU traded down $1.47 on Monday, hitting $81.70. 1,565,424 shares of the stock traded hands, compared to its average volume of 2,031,354. The business has a fifty day moving average price of $90.43 and a two-hundred day moving average price of $77.90. The firm has a market capitalization of $16.51 billion, a PE ratio of 16.85, a P/E/G ratio of 6.94 and a beta of 0.89. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86.
DocuSign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.